TABLE 1.
Parameter | Value for the parameter (n = 711)a |
---|---|
Median age (range [yr]) | 67 (55–77) |
Male sex | 467 (65.7) |
Phlebitis | 636 (89.5) |
Catheter culture | |
Negative | 12 (1.7) |
Positive | 154 (21.7) |
Not performed | 545 (76.7) |
Prior hospital admission | 99 (13.9) |
Days since hospital admission | |
Median no. of days (range) | 7 (4–12) |
0–7 | 390 (54.9) |
8–14 | 161 (22.6) |
15–21 | 60 (8.4) |
>21 | 68 (9.6) |
Unknown | 32 (4.5) |
Days since catheter placement | |
Median no. of days (range) | 5 (3–7) |
0–3 | 201 (28.3) |
4–6 | 245 (34.5) |
7–9 | 122 (17.2) |
10–12 | 46 (6.5) |
13–15 | 15 (2.1) |
16–18 | 6 (0.8) |
>19 | 7 (1.0) |
Unknown | 69 (9.7) |
Fever | 690 (97.0) |
Shock | 19 (2.7) |
Prior surgery | 77 (10.8) |
Prior nonsurgical invasive procedure | 81 (11.4) |
Urinary catheter | 133 (18.7) |
Cirrhosis | 102 (14.3) |
Diabetes | 163 (22.9) |
Pulmonary disease | 57 (8.0) |
HIV infection | 23 (3.2) |
Chronic kidney disease | 67 (9.4) |
Cardiac disease | 249 (35.0) |
Hematological malignancy | 53 (7.5) |
Solid organ malignancy | 112 (15.8) |
Neutropenia | 14 (2.0) |
Solid organ transplant | 32 (4.5) |
Corticosteroid therapy | 129 (18.1) |
McCabe, ultimately or rapidly fatal outcome | 278 (39.1) |
7-Day mortality | 26 (3.7) |
30-Day mortality | 53 (7.5) |
Persistent bacteremia | 33 (4.6) |
Correct empirical treatment | 386 (54.3) |
Prior antibiotic treatment | 169 (23.8) |
Microbial etiology | |
Gram-positive cocci | 533 (75.0) |
Staphylococcus aureus | 327 (46.0) |
Coagulase-negative staphylococci | 178 (25.0) |
Enterococcus spp. | 26 (3.7) |
Gram-negative bacilli | 162 (22.8) |
Klebsiella spp. | 40 (5.6) |
Pseudomonas aeruginosa | 32 (4.5) |
Escherichia coli | 29 (4.1) |
Enterobacter spp. | 28 (3.9) |
Serratia spp. | 5 (0.7) |
Acinetobacter spp. | 5 (0.7) |
Candida spp. | 9 (1.3) |
Values are given as number of patients (percentage) unless otherwise indicated.